Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HEW9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016553 | base conversion or substitution editing | 6 | 1 |
GO:0016554 | cytidine to uridine editing | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.335 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.342 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.430 |
CLV_NRD_NRD_1 | 293 | 295 | PF00675 | 0.409 |
CLV_NRD_NRD_1 | 302 | 304 | PF00675 | 0.377 |
CLV_NRD_NRD_1 | 359 | 361 | PF00675 | 0.359 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.646 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.342 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.430 |
CLV_PCSK_KEX2_1 | 293 | 295 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 302 | 304 | PF00082 | 0.362 |
CLV_PCSK_KEX2_1 | 488 | 490 | PF00082 | 0.466 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.621 |
CLV_PCSK_PC1ET2_1 | 488 | 490 | PF00082 | 0.466 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 255 | 259 | PF00082 | 0.372 |
CLV_PCSK_SKI1_1 | 277 | 281 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 294 | 298 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 303 | 307 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 407 | 411 | PF00082 | 0.616 |
CLV_PCSK_SKI1_1 | 491 | 495 | PF00082 | 0.387 |
CLV_Separin_Metazoa | 217 | 221 | PF03568 | 0.348 |
DEG_APCC_DBOX_1 | 293 | 301 | PF00400 | 0.325 |
DEG_APCC_DBOX_1 | 415 | 423 | PF00400 | 0.384 |
DEG_SCF_FBW7_1 | 17 | 22 | PF00400 | 0.583 |
DEG_SCF_FBW7_1 | 29 | 35 | PF00400 | 0.496 |
DEG_SPOP_SBC_1 | 34 | 38 | PF00917 | 0.692 |
DEG_SPOP_SBC_1 | 66 | 70 | PF00917 | 0.638 |
DOC_CKS1_1 | 29 | 34 | PF01111 | 0.525 |
DOC_MAPK_gen_1 | 360 | 367 | PF00069 | 0.371 |
DOC_MAPK_HePTP_8 | 463 | 475 | PF00069 | 0.423 |
DOC_MAPK_MEF2A_6 | 360 | 369 | PF00069 | 0.351 |
DOC_MAPK_MEF2A_6 | 466 | 475 | PF00069 | 0.518 |
DOC_PP2B_LxvP_1 | 104 | 107 | PF13499 | 0.528 |
DOC_PP2B_LxvP_1 | 257 | 260 | PF13499 | 0.294 |
DOC_PP4_FxxP_1 | 311 | 314 | PF00568 | 0.340 |
DOC_PP4_MxPP_1 | 328 | 331 | PF00568 | 0.433 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.664 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.626 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.624 |
DOC_USP7_MATH_1 | 332 | 336 | PF00917 | 0.476 |
DOC_USP7_MATH_1 | 456 | 460 | PF00917 | 0.379 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.692 |
DOC_USP7_MATH_1 | 72 | 76 | PF00917 | 0.594 |
DOC_USP7_UBL2_3 | 521 | 525 | PF12436 | 0.509 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.703 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.437 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.736 |
DOC_WW_Pin1_4 | 345 | 350 | PF00397 | 0.351 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.703 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.563 |
LIG_14-3-3_CanoR_1 | 187 | 191 | PF00244 | 0.337 |
LIG_14-3-3_CanoR_1 | 212 | 217 | PF00244 | 0.346 |
LIG_14-3-3_CanoR_1 | 294 | 304 | PF00244 | 0.460 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.654 |
LIG_14-3-3_CanoR_1 | 360 | 365 | PF00244 | 0.382 |
LIG_14-3-3_CanoR_1 | 376 | 383 | PF00244 | 0.351 |
LIG_14-3-3_CanoR_1 | 491 | 496 | PF00244 | 0.541 |
LIG_14-3-3_CanoR_1 | 56 | 66 | PF00244 | 0.651 |
LIG_Actin_RPEL_3 | 214 | 233 | PF02755 | 0.353 |
LIG_Clathr_ClatBox_1 | 364 | 368 | PF01394 | 0.435 |
LIG_DLG_GKlike_1 | 360 | 367 | PF00625 | 0.353 |
LIG_EH1_1 | 438 | 446 | PF00400 | 0.235 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.449 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.401 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.375 |
LIG_FHA_1 | 235 | 241 | PF00498 | 0.337 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.670 |
LIG_FHA_1 | 287 | 293 | PF00498 | 0.398 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.323 |
LIG_FHA_1 | 339 | 345 | PF00498 | 0.389 |
LIG_FHA_1 | 435 | 441 | PF00498 | 0.416 |
LIG_FHA_1 | 463 | 469 | PF00498 | 0.484 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.627 |
LIG_FHA_2 | 159 | 165 | PF00498 | 0.516 |
LIG_FHA_2 | 322 | 328 | PF00498 | 0.340 |
LIG_FHA_2 | 346 | 352 | PF00498 | 0.361 |
LIG_FHA_2 | 377 | 383 | PF00498 | 0.494 |
LIG_LIR_Apic_2 | 198 | 204 | PF02991 | 0.436 |
LIG_LIR_Apic_2 | 310 | 314 | PF02991 | 0.347 |
LIG_LIR_Gen_1 | 18 | 25 | PF02991 | 0.610 |
LIG_LIR_Gen_1 | 397 | 404 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.607 |
LIG_LIR_Nem_3 | 397 | 402 | PF02991 | 0.416 |
LIG_NRBOX | 500 | 506 | PF00104 | 0.351 |
LIG_NRBOX | 515 | 521 | PF00104 | 0.343 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.623 |
LIG_SH2_CRK | 207 | 211 | PF00017 | 0.463 |
LIG_SH2_CRK | 399 | 403 | PF00017 | 0.393 |
LIG_SH2_NCK_1 | 263 | 267 | PF00017 | 0.386 |
LIG_SH2_NCK_1 | 399 | 403 | PF00017 | 0.412 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.323 |
LIG_SH2_STAP1 | 20 | 24 | PF00017 | 0.623 |
LIG_SH2_STAP1 | 207 | 211 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 323 | 326 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 454 | 457 | PF00017 | 0.352 |
LIG_SH3_3 | 223 | 229 | PF00018 | 0.479 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.509 |
LIG_SUMO_SIM_anti_2 | 161 | 169 | PF11976 | 0.507 |
LIG_SUMO_SIM_anti_2 | 215 | 220 | PF11976 | 0.369 |
LIG_SUMO_SIM_par_1 | 212 | 217 | PF11976 | 0.361 |
LIG_SUMO_SIM_par_1 | 390 | 397 | PF11976 | 0.415 |
LIG_TRAF2_1 | 348 | 351 | PF00917 | 0.507 |
LIG_TYR_ITSM | 16 | 23 | PF00017 | 0.610 |
LIG_TYR_ITSM | 395 | 402 | PF00017 | 0.442 |
MOD_CDK_SPK_2 | 51 | 56 | PF00069 | 0.607 |
MOD_CDK_SPxK_1 | 51 | 57 | PF00069 | 0.609 |
MOD_CK1_1 | 195 | 201 | PF00069 | 0.274 |
MOD_CK1_1 | 298 | 304 | PF00069 | 0.321 |
MOD_CK1_1 | 345 | 351 | PF00069 | 0.518 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.708 |
MOD_CK1_1 | 394 | 400 | PF00069 | 0.493 |
MOD_CK1_1 | 459 | 465 | PF00069 | 0.391 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.666 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.617 |
MOD_CK2_1 | 158 | 164 | PF00069 | 0.512 |
MOD_CK2_1 | 345 | 351 | PF00069 | 0.375 |
MOD_CK2_1 | 376 | 382 | PF00069 | 0.500 |
MOD_Cter_Amidation | 486 | 489 | PF01082 | 0.477 |
MOD_GlcNHglycan | 297 | 300 | PF01048 | 0.445 |
MOD_GlcNHglycan | 389 | 392 | PF01048 | 0.463 |
MOD_GlcNHglycan | 404 | 407 | PF01048 | 0.634 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.691 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.592 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.507 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.376 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.665 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.289 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.345 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.588 |
MOD_GSK3_1 | 338 | 345 | PF00069 | 0.521 |
MOD_GSK3_1 | 387 | 394 | PF00069 | 0.474 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.583 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.682 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.334 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.309 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.285 |
MOD_NEK2_1 | 278 | 283 | PF00069 | 0.375 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.701 |
MOD_NEK2_1 | 387 | 392 | PF00069 | 0.456 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.781 |
MOD_NEK2_2 | 192 | 197 | PF00069 | 0.345 |
MOD_NEK2_2 | 391 | 396 | PF00069 | 0.320 |
MOD_PIKK_1 | 353 | 359 | PF00454 | 0.388 |
MOD_PIKK_1 | 46 | 52 | PF00454 | 0.492 |
MOD_PKA_1 | 360 | 366 | PF00069 | 0.403 |
MOD_PKA_2 | 186 | 192 | PF00069 | 0.334 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.619 |
MOD_PKA_2 | 338 | 344 | PF00069 | 0.388 |
MOD_PKA_2 | 400 | 406 | PF00069 | 0.562 |
MOD_PKB_1 | 489 | 497 | PF00069 | 0.397 |
MOD_Plk_1 | 253 | 259 | PF00069 | 0.421 |
MOD_Plk_1 | 431 | 437 | PF00069 | 0.503 |
MOD_Plk_4 | 19 | 25 | PF00069 | 0.729 |
MOD_Plk_4 | 206 | 212 | PF00069 | 0.452 |
MOD_Plk_4 | 253 | 259 | PF00069 | 0.421 |
MOD_Plk_4 | 312 | 318 | PF00069 | 0.330 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.617 |
MOD_Plk_4 | 459 | 465 | PF00069 | 0.398 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.652 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.702 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.433 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.737 |
MOD_ProDKin_1 | 345 | 351 | PF00069 | 0.348 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.705 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.565 |
TRG_DiLeu_BaEn_1 | 164 | 169 | PF01217 | 0.378 |
TRG_DiLeu_BaEn_1 | 254 | 259 | PF01217 | 0.511 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.753 |
TRG_ENDOCYTIC_2 | 207 | 210 | PF00928 | 0.419 |
TRG_ENDOCYTIC_2 | 263 | 266 | PF00928 | 0.388 |
TRG_ENDOCYTIC_2 | 399 | 402 | PF00928 | 0.385 |
TRG_ER_diArg_1 | 186 | 188 | PF00400 | 0.335 |
TRG_ER_diArg_1 | 219 | 221 | PF00400 | 0.341 |
TRG_ER_diArg_1 | 292 | 294 | PF00400 | 0.386 |
TRG_ER_diArg_1 | 302 | 304 | PF00400 | 0.376 |
TRG_ER_diArg_1 | 489 | 492 | PF00400 | 0.438 |
TRG_ER_diArg_1 | 55 | 57 | PF00400 | 0.648 |
TRG_NES_CRM1_1 | 357 | 371 | PF08389 | 0.406 |
TRG_NLS_MonoExtC_3 | 487 | 492 | PF00514 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 212 | 217 | PF00026 | 0.346 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IGU4 | Leptomonas seymouri | 76% | 94% |
A0A0S4JSB1 | Bodo saltans | 58% | 100% |
A0A1X0NS86 | Trypanosomatidae | 67% | 99% |
A0A3Q8IDM7 | Leishmania donovani | 90% | 99% |
A0A422N6M4 | Trypanosoma rangeli | 62% | 100% |
A4I243 | Leishmania infantum | 90% | 99% |
C9ZRW1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 99% |
E9AY93 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q980 | Leishmania major | 88% | 100% |
V5B995 | Trypanosoma cruzi | 63% | 100% |